Cyclosporine 0.09% Solution (Cequa) for Dry Eye Disease
Date: July 29, 2019
Issue #:
1577Summary:
The FDA has approved cyclosporine 0.09% ophthalmic
solution (Cequa– Sun) to increase tear production
in patients with keratoconjunctivitis sicca (dry eye
disease).Restasis, a 0.05% cyclosporine emulsion,
was approved in the US in 2003 for the same indication.
Source: The Medical Letter - Category: Drugs & Pharmacology Authors: admin Tags: Cequa Cyclosporine Dry eye disease lifitegrast Restasis Verkazia Xiidra Source Type: research